Article Text

Download PDFPDF
Oral liquid medicines for children: the issues of choice
  1. Mandy Wan1,2,
  2. Andrew Wignell3,
  3. Stephen Tomlin4
  1. 1 Evelina Pharmacy, Guys' & St Thomas' NHS Foundation Trust, London, UK
  2. 2 Institute of Pharmaceutical Science, King's College London, London, UK
  3. 3 Pharmacy, Nottingham University Hospitals NHS Trust, Nottingham, UK
  4. 4 Pharmacy, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
  1. Correspondence to Dr Mandy Wan, Evelina Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK; mandy.wan{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Offering choices allows accommodation of patient preferences. For many drugs, the availability of different dosage forms is designed to meet individuals’ needs, some of whom, for example, may have difficulties swallowing tablets. Accordingly, having more than one concentration of the same drug in liquid form allows us to further tailor the volume to be administered.

However, in practice, choices are sometimes ‘limited’, at least on an organisational level. Among other good reasons for restricting the product range, there simply is not enough space for a pharmacy to stock every single product that is marketed. For oral liquid medicines, the situation is such that one pharmacy may stock only a particular concentration while another pharmacy may keep one of a different concentration. In the …

View Full Text


  • Contributors All authors have contributed equally.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests AW and ST are committee members of the Neonatal and Paediatric Pharmacy Group and have contributed to the development of the position statement on standardised concentrations of unlicensed liquid medicines in children.

  • Provenance and peer review Not commissioned; externally peer reviewed.